289 related articles for article (PubMed ID: 24449674)
1. Comparison of TSH Levels with Liquid Formulation Versus Tablet Formulations of Levothyroxine in the Treatment of Adult Hypothyroidism.
Brancato D; Scorsone A; Saura G; Ferrara L; Di Noto A; Aiello V; Fleres M; Provenzano V
Endocr Pract; 2014 Jul; 20(7):657-62. PubMed ID: 24449674
[TBL] [Abstract][Full Text] [Related]
2. Switching levothyroxine from the tablet to the oral solution formulation corrects the impaired absorption of levothyroxine induced by proton-pump inhibitors.
Vita R; Saraceno G; Trimarchi F; Benvenga S
J Clin Endocrinol Metab; 2014 Dec; 99(12):4481-6. PubMed ID: 25259910
[TBL] [Abstract][Full Text] [Related]
3. Delaying Thyroxine Until Positive Beta-Human Chorionic Gonadotropin is Safe for Patients Receiving Fertility Therapy: Applying New ATA Guidelines to Subclinical Hypothyroidism.
Goldberg AS; Sujana Kumar S; Greenblatt E; Lega IC; Shapiro H
J Obstet Gynaecol Can; 2018 Mar; 40(3):299-303. PubMed ID: 28923288
[TBL] [Abstract][Full Text] [Related]
4. Levothyroxine liquid solution versus tablet form for replacement treatment in pregnant women.
Cappelli C; Negro R; Pirola I; Gandossi E; Agosti B; Castellano M
Gynecol Endocrinol; 2016; 32(4):290-2. PubMed ID: 26585420
[TBL] [Abstract][Full Text] [Related]
5. Drug interactions in users of tablet vs. oral liquid levothyroxine formulations: a real-world evidence study in primary care.
Guglielmi V; Bellia A; Bianchini E; Medea G; Cricelli I; Sbraccia P; Lauro D; Cricelli C; Lapi F
Endocrine; 2018 Mar; 59(3):585-592. PubMed ID: 28905202
[TBL] [Abstract][Full Text] [Related]
6. Tablet and oral liquid L-thyroxine formulation in the treatment of naïve hypothyroid patients with Helicobacter pylori infection.
Ribichini D; Fiorini G; Repaci A; Castelli V; Gatta L; Vaira D; Pasquali R
Endocrine; 2017 Sep; 57(3):394-401. PubMed ID: 27848196
[TBL] [Abstract][Full Text] [Related]
7. TSH evaluation in hypothyroid patients assuming liquid levothyroxine at breakfast or 30 min before breakfast.
Pirola I; Gandossi E; Brancato D; Marini F; Cristiano A; Delbarba A; Agosti B; Castellano M; Cappelli C
J Endocrinol Invest; 2018 Nov; 41(11):1301-1306. PubMed ID: 29582344
[TBL] [Abstract][Full Text] [Related]
8. IN PATIENTS WITH SUBCLINICAL HYPOTHYROIDISM WHILE IN THERAPY WITH TABLET L-T4, THE LIQUID L-T4 FORMULATION IS MORE EFFECTIVE IN RESTORING EUTHYROIDISM.
Fallahi P; Ferrari SM; Antonelli A
Endocr Pract; 2017 Feb; 23(2):170-174. PubMed ID: 27849377
[TBL] [Abstract][Full Text] [Related]
9. Alternative routes of levothyroxine administration for hypothyroidism.
Ritter MJ; Gupta S; Hennessey JV
Curr Opin Endocrinol Diabetes Obes; 2020 Oct; 27(5):318-322. PubMed ID: 32740045
[TBL] [Abstract][Full Text] [Related]
10. Effect of proton pump inhibitors on serum thyroid-stimulating hormone level in euthyroid patients treated with levothyroxine for hypothyroidism.
Sachmechi I; Reich DM; Aninyei M; Wibowo F; Gupta G; Kim PJ
Endocr Pract; 2007; 13(4):345-9. PubMed ID: 17669709
[TBL] [Abstract][Full Text] [Related]
11. Liquid Thyroxine Improves Outcomes in Hypothyroid Patients With Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome.
Henderson BB; Smith SP; Mengelkamp ME; Rhymer EK; Gray KN; Jackson AG; Henry SF; Chuang S; Stavrakas EH; Blair OM; Heaps M
Endocr Pract; 2024 Jun; 30(6):505-512. PubMed ID: 38490469
[TBL] [Abstract][Full Text] [Related]
12. A Double-Blind Placebo-Controlled Trial of Liquid Thyroxine Ingested at Breakfast: Results of the TICO Study.
Cappelli C; Pirola I; Daffini L; Formenti A; Iacobello C; Cristiano A; Gandossi E; Agabiti Rosei E; Castellano M
Thyroid; 2016 Feb; 26(2):197-202. PubMed ID: 26586610
[TBL] [Abstract][Full Text] [Related]
13. The relationship of preconception thyrotropin levels to requirements for increasing the levothyroxine dose during pregnancy in women with primary hypothyroidism.
Abalovich M; Alcaraz G; Kleiman-Rubinsztein J; Pavlove MM; Cornelio C; Levalle O; Gutierrez S
Thyroid; 2010 Oct; 20(10):1175-8. PubMed ID: 20860419
[TBL] [Abstract][Full Text] [Related]
14. Expert opinion on liquid L-thyroxine usage in hypothyroid patients and new liquid thyroxine formulation - Tirosint SOL [Opinia ekspertów dotycząca stosowania płynnej postaci lewotyroksyny oraz nowego preparatu Tirosint SOL u chorych na niedoczynność tarczycy].
Gietka-Czernel M; Hubalewska-Dydejczyk A; Kos-Kudła B; Lewiński A; Ruchała M; Syrenicz A; Zgliczyński W
Endokrynol Pol; 2020; 71(5):441-465. PubMed ID: 33202031
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Levothyroxine Sodium Soft Gelatin Capsules in Thyroidectomized Patients Taking Proton Pump Inhibitors: An Open-Label Study.
Sachmechi I; Lucas KJ; Stonesifer LD; Ansley JF; Sack P; Celi FS; Scarsi C; Lanzi G; Wartofsky L; Burman KD
Thyroid; 2023 Dec; 33(12):1414-1422. PubMed ID: 37885233
[No Abstract] [Full Text] [Related]
16. Treatment pattern and frequency of serum TSH measurement in users of different levothyroxine formulations: a population-based study during the years 2009-2015.
Ferrara R; Ientile V; Arcoraci V; Ferrajolo C; Piccinni C; Fontana A; Benvenga S; Trifirò G
Endocrine; 2017 Oct; 58(1):143-152. PubMed ID: 28155170
[TBL] [Abstract][Full Text] [Related]
17. The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine.
Antonelli A; Elia G; Ragusa F; Paparo SR; Cavallini G; Benvenga S; Ferrari SM; Fallahi P
Front Endocrinol (Lausanne); 2021; 12():633587. PubMed ID: 33790863
[TBL] [Abstract][Full Text] [Related]
18. Levothyroxine Cessation After Thyroid Lobectomy for Papillary Thyroid Cancer Can Be Achieved at the Same Rate as that for Benign Tumors Regardless of the Duration of Thyroid-stimulating Hormone Suppression.
Na YM; Cho JS; Park MH
Anticancer Res; 2021 Nov; 41(11):5713-5721. PubMed ID: 34732444
[TBL] [Abstract][Full Text] [Related]
19. Switch from tablet levothyroxine to oral solution resolved reduced absorption by intestinal parasitosis.
Tortora A; La Sala D; Vitale M
Endocrinol Diabetes Metab Case Rep; 2019 Mar; 2019():. PubMed ID: 30897550
[TBL] [Abstract][Full Text] [Related]
20. ITALIAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS STATEMENT-REPLACEMENT THERAPY FOR PRIMARY HYPOTHYROIDISM: A BRIEF GUIDE FOR CLINICAL PRACTICE.
Guglielmi R; Frasoldati A; Zini M; Grimaldi F; Gharib H; Garber JR; Papini E
Endocr Pract; 2016 Nov; 22(11):1319-1326. PubMed ID: 27482609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
